The study
How we will find out if it helps
The study is how we will find out whether Asclepiad makes a real difference to how people feel, and we are doing it in the open, with the plan registered before anyone outside the team had taken part. It is optional.

I'll put it as I would to a colleague. Everyone in the study gets the same app. We compare how much each person uses it with how their answers change. If the two move together, that is an association, not proof: people who use it more may differ in ways that have nothing to do with us. It's the most this design can show, and I'd rather you heard its limit from me.
The problem with asking
"We asked people and they felt better" isn't good enough.
Three things make an app like this look effective whether or not it is. All three push the same way.
So the only useful question is compared to what? Without an answer to that, a chart of our users feeling better over time is marketing — and anyone who reads research for a living will read it as marketing. A trial answers it by giving some people something different. This study doesn't: everyone in it gets the same, full app. So it can't answer that question in full, and the next section says what it can show instead.
We registered our analysis plan publicly on 19 October 2026, four days after the study opened. The plan is here: https://osf.io/zbrdt/
What we compare
How much you use it, against how your answers change.
Everyone in the study gets the same app and uses it as much or as little as they like. We put how much each person actually used it beside their answers over six months.
What it can show
Whether people who use it more tend to answer differently from people who use it less, and by how much. If there is no difference, that is a result too, and we'll publish it.
What it can't show
That the app caused any difference. People choose how much they use it, so the people who use it most may differ in ways that have nothing to do with us. Every result we publish will say so beside the number.
The schedule
Four sets of questions, a few minutes each.
The first one has to come first. A starting point measured after a good first session isn't a starting point — it's already part of the result, and it's the easiest thing in a study like this to get wrong.
- 1Before your first sessionThere is one invitation, shown once in the app, after you make your account and before your first session.
- 2Two weeksEarly change, and how much you've actually used it.
- 3Two monthsThe point the whole study turns on. This is the point we committed to in advance for the analysis.
- 4Six monthsWhether anything that changed has stayed changed.
What we ask
Questions other people can check us against.
For the main measures, we use scales that already exist, with their standard wording, unchanged. A questionnaire we wrote ourselves would produce numbers nobody can interpret — including us.
WHO-5
Five questions on well-being, used in hundreds of published studies. Because the wording is standard, our number means the same thing as everyone else's.
Four questions on personal well-being
The UK Office for National Statistics asks these four: how satisfied you are with your life nowadays, how worthwhile the things you do feel, how happy you felt yesterday, and how anxious you felt yesterday. They have national reference data behind them, so we may also set our numbers beside the general population, as a side look; the registered plan's main question is about people who use the app more.
What, if anything, changed
Five things you can tick if they happened, and one open question: what, if anything, have you done differently? We wrote these ourselves because no standard scale exists for it, and we keep them the same at every wave. Asked from two weeks on. The open question has no scale behind it.
Being honest about it
The four things that would let us fool you.
Joining the study
You join inside the app, or not at all.
The study is optional. The app shows you one invitation, after you have set it up; you can say no and use everything else. The study is for people 18 and over, and is not yet offered in every language of the app. We are working on the rest. Taking part is not anonymous: we link your answers to your account so we can compare them with your sessions.
This is a study of our own product, not an independent clinical trial, and we are not a medical service. If we ever publish this work in a journal it will go through external ethical review first.
See for yourself in the app.
We do not ask for your name or email.